Fig. 7

conferred protection of immunized mice with vaccine or recombinant proteins against B. melitensis M16. Mean comparison of treatments were carried out employing Tukey’s test with significance level of 0.05. Results are shown as mean ± SD of the log10CFU of B. melitensis M16per spleen (n = 4), **P < 0.01 and ***P < 0.001